TCM
LONA

Tradewinds Capital Management’s LeonaBio Inc LONA Stock Holding History

Tradewinds Capital Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-852
Closed -$115K – 454
2022
Q1 		$115K Buy
+852
New +$89.8K 0.02% 162

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tradewinds Capital Management's LONA Position: Q2 2022 in Review

Tradewinds Capital Management sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 852 shares — an estimated $115K sold.

Tradewinds Capital Management first reported a position in LONA in Q1 2022 and held it in 1 quarter. The position peaked at $115K in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • Tradewinds Capital Management reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 852 LeonaBio Inc shares in Q2 2022, an estimated $115K.
  • Tradewinds Capital Management first reported a position in LeonaBio Inc in Q1 2022 and held it in 1 quarter.
  • Tradewinds Capital Management's LeonaBio Inc position peaked at $115K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.